SCWorx Resumes Nasdaq Trading After Panel Reverses Delisting

GlobeNewswire··US·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

SCWorx Corp. said its common stock resumed trading on The Nasdaq Capital Market on October 7, 2026, after the Nasdaq Hearings Panel granted the company's request for reconsideration of its September 17, 2026 delisting decision and determined it had regained compliance with continued listing requirements, subject to conditions including a one-year Panel Monitor. The Middleton, Massachusetts-based healthcare supply chain data management company reported second-quarter 2026 revenue of approximately $706,000, up from approximately $683,000 a year earlier, with gross profit rising approximately 83% to approximately $330,000. For the first six months of 2026, gross profit increased approximately 122% to approximately $705,000 from approximately $317,000 in the prior-year period, despite comparatively modest revenue growth of approximately $1.45 million versus approximately $1.40 million. The company's net loss for the second quarter narrowed to approximately $121,000 from approximately $1.9 million a year earlier, and its first-half net loss fell to approximately $295,000 from approximately $2.4 million, helped by the absence of approximately $1.7 million of interest expense and debt discount amortization tied to convertible notes that are no longer outstanding. Cash used in operating activities declined to approximately $258,000 in the first half of 2026 from approximately $1.1 million a year earlier, and SCWorx held cash of approximately $1.3 million at June 30, 2026, after raising gross proceeds of $938,000 in a September 2026 private placement of common stock and warrants. Chief Executive Officer Tim Hannibal said the company's focus remains on the underlying business, citing continued investment in its AI-enabled Data Management Model and new customer agreements, including a not-for-profit teaching hospital and a two-year agreement with one of Massachusetts' largest integrated delivery networks.

Impact on assets 1

Health Care▲
Scworx Corp
WORX
▲ PositiveCapitalRegulationrelevance

Q2 and first-half gross profit rose sharply and net loss narrowed, aided by the absence of ~$1.7M convertible-note interest and debt-discount amortization.